Bischof P

No ORCID on file · 6 papers in corpus
article 2010
Gynecologic and obstetric investigation ·doi:10.1159/000293759

Pituitary desensitization following infusion of gonadotropin-releasing hormone (GnRH) is measurable if bioactivity instead of immunoreactivity is considered. We hypothesized that GnRH agonist therapy induces the same kind of desensitization…

other 2010
Neuro endocrinology letters

OBJECTIVE: Proliferation, migration and invasion of trophoblastic cells into the maternal endometrium are essential steps in human embryo implantation and placentation. Trophoblast invasion is normally limited in time, only during first and…

other 1994
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a138768

It has been shown that rat and human endometria have the capacity to produce complement component 3 (C3). In rats, endometrial C3 is an oestrogen-dependent protein produced and secreted by glandular cells. The cell responsible for the synth…

article 1992
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a137552

CA 125, a marker of ovarian cancer, is also increased in otherwise normal women suffering from, for example, pelvic inflammatory disease, endometriosis and adenomyosis. The tissues suspected of producing CA 125 in normal women include the e…

other 1987
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1987.tb02353.x

Plasma levels of CA 125 were determined in 113 patients with ovarian cancer of epithelial origin. Of these, 69 patients had CA 125 measured before the first laparotomy and 84.6% of them had a CA 125 level greater than 35 U/ml. In 87 of the …

article 1986
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a136445

Cancer antigen 125 (CA125) is an antigenic determinant defined by a murine monoclonal antibody and is present on the surface of some ovarian tumours. Using an immunoradiometric assay CA125 immunoreactivity was found in amniotic fluid and de…